Vitiligo gene study seeks clues in Body's inflammatory response
NCT ID NCT07232238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a specific gene (TRPM2) might be linked to inflammation in people with vitiligo, a skin condition that causes white patches. Researchers will compare blood samples from 60 adults with vitiligo and healthy volunteers to see if certain gene variations affect inflammation levels. The goal is to better understand the disease, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aswan University Hospital
Aswān, Aswan Governorate, 81528, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Real-World data unlock better skin disease care?
- New ointment aims to restore skin color in vitiligo
- Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
- New vitiligo registry aims to uncover disease trends in 2,500 patients
- Scientists probe immune secrets of four skin diseases
- Lamp vs laser: which light works best for vitiligo?